the impact of mrd standardized assessment by fdg-pet/ct in patients enrolled in the forte trial
Published 10 months ago • 76 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
2:15
the role of pet/ct in assessing early treatment response in patients with ndmm
-
2:19
standardization of 18f-fdg pet/ct according to deauville criteria for mrd evaluation in mm patients
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
3:28
standardization of pet scans for mrd in multiple myeloma
-
5:46
mrd: standardization and application
-
![[nm] pet ct | search pattern](https://i.ytimg.com/vi/VsspJQVPmpc/mqdefault.jpg)
13:21
[nm] pet ct | search pattern
-
13:46
cardiac ct assessment of structural heart disease (john j. mahmarian, md)
-
3:38
your radiologist explains: thyroid scan procedure
-
2:41
assessing the prognostic value of ngs-based mrd in adults with all undergoing sct
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
1:06
mrd evaluation by mfc and ngs for mm
-
1:09
taking mrd from trials to the clinic
-
2:03
updated fda mrd guidelines for hematological malignancies
-
1:30
the prognostic value of patient-reported outcomes in mds
-
3:48
mrd-driven hsct for all
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
3:11
assessment of mrd in aml
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
3:01
the predictive value of stereotyped bcr subsets in cll
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
1:00
mds: what's the impact of early diagnosis?